Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of Tuesday, October 6, 2026.
EARNINGS PER SHARE (EPS)
N/A
Market Cap
$738.45M
Earnings Per Share (EPS)
-1.18
TTM Avg
-1.05
3Y Avg
-1.11
5Y Avg
-0.92
Market Cap
$726.75M
Earnings Per Share (EPS)
-1.41
TTM Avg
-1.23
3Y Avg
-0.97
5Y Avg
-1.16
Market Cap
$723.48M
Earnings Per Share (EPS)
-1.55
TTM Avg
-1.25
3Y Avg
-1.99
5Y Avg
-2.90
Market Cap
$711.21M
Earnings Per Share (EPS)
-4.74
TTM Avg
-5.08
3Y Avg
-296.60
5Y Avg
-1006.80
Market Cap
$764.31M
Earnings Per Share (EPS)
0.84
TTM Avg
0.43
3Y Avg
-11.54
5Y Avg
-7.53
Market Cap
$765.29M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.23
3Y Avg
-1.23
5Y Avg
-1.23
Market Cap
$709.36M
Earnings Per Share (EPS)
1.24
TTM Avg
2.06
3Y Avg
1.25
5Y Avg
1.30
Market Cap
$704.20M
Earnings Per Share (EPS)
-0.62
TTM Avg
-0.28
3Y Avg
-0.16
5Y Avg
-0.10
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apnimed, Inc. (APMD) | $737.53M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $738.45M | -1.18 | -1.05 | -1.11 | -0.92 |
| Candel Therapeutics, Inc. (CADL)vs › | $726.75M | -1.41 | -1.23 | -0.97 | -1.16 |
| Achieve Life Sciences, Inc. (ACHV)vs › | $723.48M | -1.55 | -1.25 | -1.99 | -2.90 |
| Avalo Therapeutics, Inc. (AVTX)vs › | $711.21M | -4.74 | -5.08 | -296.60 | -1006.80 |
| Mesa Laboratories, Inc. (MLAB)vs › | $764.31M | 0.84 | 0.43 | -11.54 | -7.53 |
| Attovia Therapeutics, Inc. (ATTO)vs › | $765.29M | N/A | -1.23 | -1.23 | -1.23 |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.36M | 1.24 | 2.06 | 1.25 | 1.30 |
| Cytek Biosciences, Inc. (CTKB)vs › | $704.20M | -0.62 | -0.28 | -0.16 | -0.10 |
| Sana Biotechnology, Inc. (SANA)vs › | $775.04M | -0.75 | -1.06 | -1.25 | -1.46 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
